FutureLearn uses cookies to enhance your experience of the website. All but strictly necessary cookies are currently disabled for this browser. Turn on JavaScript to exercise your cookie preferences for all non-essential cookies. You can read FutureLearn's Cookie policy here.

Learn more about this course.

Treatment of VL: antileishmanial drugs

This step covers the main therapeutic drugs used for the treatment of visceral leishmaniasis (VL) and post kala-azar dermal leishmaniasis (PKDL).

Which are the main therapeutic drugs used for the treatment of visceral leishmaniasis and PKDL?

Want to keep learning?

This content is taken from London School of Hygiene & Tropical Medicine online course

Control and Elimination of Visceral Leishmaniasis

See other articles from this course

This article is from the free online

Control and Elimination of Visceral Leishmaniasis

Created by

Join Now